Prospective delegates are invited to submit research abstracts for the Annual ENTIS meeting which will be held in Leiden (NL) from the 3rd to 5th September. The abstract submission deadline is 31st March 2026. Authors will be notified of acceptance by 30th April 2026. Please see here for the abstract submission template and instructions for authors More information about the […]
» Read more
Researchers from Izmir TIS (Terafar), the Department of Medical Pharmacology, Marmara University School of Medicine, and the Turkish Medicines and Medical Devices Agency have published a systematic review and meta-analysis of pregnancy outcomes following paternal methotrexate exposure. More information is available here. Photo by Towfiqu barbhuiya, downloaded from Pexels.
» Read more
Professor Per Damkier (the outgoing Chair of the ENTIS Scientific Committee) and Dr Matitiahu Berkovitch (President of ENTIS) have published a commentary in the British Journal of Obstetrics and Gynaecology discussing the FDA panel discussion (broadcast 21 July 2025) about the safety of selective serotonin reuptake inhibitors (SSRI) in pregnancy. Photo by Sam Szuchan on Unsplash
» Read more
ENTIS does not support the recent claims relating to autism risk following paracetamol use in pregnancy
» Read more
Members are now able to view the presentation slides from the Thessaloniki conference in the members area (see Presentations from the most recent annual meeting).
» Read more
Between the 11th and 14th September 2025, Associate Professor Chrysanthi Sardeli (Department of Clinical Pharmacology, Aristotle University of Thessaloniki) welcomed international delegates to the 36th ENTIS conference in the ancient and historic city of Thessaloniki in Greece. The scientific programme was highly engaging, featuring presentations from internationally renown researchers and leaders in the fields of clinical pharmacology, toxicology, pharmacoepidemiology and […]
» Read more
A sub-study within the ConcePTION project led by researchers from the Swiss Teratology Information Service and the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven in Belgium has resulted in the development of a clinical decision tree to guide researchers in selecting the most appropriate methodological approach for evaluating the safety of medication during breastfeeding. More details about the about […]
» Read more
A new collaboration between the Teratology Information Service CRAT (Centre de Reference sur les Agents Tératogènes) and the French Network of Pharmacovigilance Centres has produced the largest to date prospective case series of CFTR modulator exposed pregnancies. The article has been published in the Journal of Cystic Fibrosis, and more details are available here. Photo by Robina Weermeijer on Unsplash
» Read more
